Opening Asia for Russia

20 million doses of AstraZeneca vaccine to go to South Korea

10.02.2021 107 просмотров

South Korean authorities have approved the AstraZeneca vaccine for all persons over 18 years of age.

The Food and Drug Administration of the Republic of Korea has approved the use of the vaccine by the British-Swedish company AstraZeneca (“AstraZeneca”) for the entire adult population, including those over 65 years of age. The Yonhap agency reported this on Wednesday.

The South Korean regulator put forward one condition - the vaccine manufacturer must continue to provide data on the third stage of clinical trials. While the FDA approved the use of the drug in the general adult population, it advised healthcare providers to be especially careful when deciding whether to vaccinate older people. The reason for this was the lack of data on the effectiveness of the vaccine among this age group. Yonhap notes that experts have found no problems with the safety and efficacy of the vaccine, but people over 65 years old made up only 7.4% of the participants in clinical trials.

5 million doses. In total, South Korea agreed to supply 20 million doses. Vaccination with this vaccine in South Korea will begin on February 26. Also in the first half of 2021, almost 2.6 million doses of the British-Swedish vaccine are expected to be delivered through the international COVAX mechanism (Kovax).

Vaccination in the country will be free and voluntary. At the first stage, it is planned to vaccinate health workers and people who are in direct contact with patients with COVID-19. Mass vaccination of citizens will start in the third quarter, by November, the authorities expect to form herd immunity among the country's population.

Новости партнёров